Would you have Interstitial Lung Disease when you have Hepatitis C?


Interstitial lung disease is found among people with Hepatitis c, especially for people who are male, 60+ old, take medication Rebetol and have Hypertension. We study 280 people who have Interstitial lung disease and Hepatitis c from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Hepatitis C

Hepatitis c can be treated by Ribavirin, Pegasys, Peginterferon, Incivek, Ribasphere (latest reports from 99,153 Hepatitis c patients)

Interstitial Lung Disease

Interstitial lung disease has been reported by people with rheumatoid arthritis, high blood pressure, preventive health care, lung cancer - non-small cell, breast cancer (latest reports from 28,509 Interstitial lung disease patients).

On Oct, 21, 2016

280 people who have Hepatitis C and Interstitial Lung Disease are studied.

Number of reports submitted per year:

Would you have Interstitial lung disease when you have Hepatitis c?

Gender of people who have Hepatitis C and experience Interstitial Lung Disease *:

  • female: 36.5 %
  • male: 63.5 %

Age of people who have Hepatitis C and experience Interstitial Lung Disease *:

  • 0-1: 0.41 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.04 %
  • 40-49: 11.02 %
  • 50-59: 31.02 %
  • 60+: 55.51 %

Top co-existing conditions for these people *:

  • Hypertension (18 people, 6.43%)
  • Prophylaxis (11 people, 3.93%)
  • Depression (7 people, 2.50%)
  • Prostate Cancer (6 people, 2.14%)
  • Gastritis (6 people, 2.14%)

Most common drugs for these people *:

  • Rebetol (103 people, 36.79%)
  • Pegasys (73 people, 26.07%)
  • Peg-Intron (65 people, 23.21%)
  • Ribavirin (61 people, 21.79%)
  • Copegus (31 people, 11.07%)

Top symptoms for these people *:

  • Pyrexia (34 people, 12.14%)
  • Cough (26 people, 9.29%)
  • Anaemia (26 people, 9.29%)
  • Pleural Effusion (21 people, 7.50%)
  • Dyspnoea (21 people, 7.50%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Interstitial lung disease and Hepatitis c?

Browse all symptoms of Hepatitis c

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Interstitial lung disease

Interstitial lung disease

Other conditions that could case Interstitial lung disease

Interstitial lung disease

Related studies

Can you answer these questions?

More questions for: Hepatitis c, Interstitial lung disease

You may be interested in these reviews

More reviews for: Hepatitis c, Interstitial lung disease

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.